All In Biotech

Drug Trial Radar · NCT00301925

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery

Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer (TACT2)

Last checked: Nov 19, 2026Latest source record: Aug 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 4,400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

4,400

Planned (sponsor's estimate)

Start

Dec 16, 2005

Primary completion

Sep 2024

Study completion Sep 2024

Sponsor

Lead sponsor
Institute of Cancer Research, United KingdomAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 13, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy after surgery may kill any remaining tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating early stage breast cancer that has been removed by surgery. PURPOSE: This randomized phase III trial is studying four different combination chemotherapy regimens to compare how well they work in treating patients with early stage breast cancer that has been removed by surgery.

Conditions

  • Breast Cancer

Interventions

  • pegfilgrastimBiological

  • capecitabineDrug

  • cyclophosphamideDrug

  • epirubicin hydrochlorideDrug

  • fluorouracilDrug

  • methotrexateDrug

  • adjuvant therapyProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free survival (DFS) at 5 years

Locations

152 sites in 1 country. Site status is shown where the registry gives one.

  • Barnet General Hospital

    Barnet, Hertfordshire, United Kingdom

  • William Harvey Hospital

    Ashford-Kent, England, United Kingdom

  • Wansbeck General Hospital

    Ashington, England, United Kingdom

  • Tameside General Hospital

    Ashton-under-Lyne, England, United Kingdom

  • North Devon District Hospital

    Barnstaple, England, United Kingdom

  • Furness General Hospital

    Barrow in Furness, England, United Kingdom

  • Basildon University Hospital

    Basildon, England, United Kingdom

  • Basingstoke and North Hampshire NHS Foundation Trust

    Basingstoke, England, United Kingdom

  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust

    Birmingham, England, United Kingdom

  • City Hospital - Birmingham

    Birmingham, England, United Kingdom

  • Birmingham Heartlands Hospital

    Birmingham, England, United Kingdom

  • Royal Blackburn Hospital

    Blackburn, England, United Kingdom

  • Blackpool Victoria Hospital

    Blackpool, England, United Kingdom

  • Royal Bolton Hospital

    Bolton, Lancashire, England, United Kingdom

  • Bradford Royal Infirmary

    Bradford, England, United Kingdom

  • Sussex Cancer Centre at Royal Sussex County Hospital

    Brighton, England, United Kingdom

  • Bristol Haematology and Oncology Centre

    Bristol, England, United Kingdom

  • Broomfield Hospital

    Broomefield, England, United Kingdom

  • Burnley General Hospital

    Burnley, England, United Kingdom

  • Queen's Hospital

    Burton-on-Trent, England, United Kingdom

  • West Suffolk Hospital

    Bury St Edmunds, England, United Kingdom

  • Addenbrooke's Hospital

    Cambridge, England, United Kingdom

  • Kent and Canterbury Hospital

    Canterbury, England, United Kingdom

  • Cheltenham General Hospital

    Cheltenham, England, United Kingdom

  • Halton Hospital

    Cheshire, England, United Kingdom

  • Chesterfield Royal Hospital

    Chesterfield, England, United Kingdom

  • Saint Richards Hospital

    Chichester, England, United Kingdom

  • Essex County Hospital

    Colchester, England, United Kingdom

  • Walsgrave Hospital

    Coventry, England, United Kingdom

  • Darent Valley Hospital

    Dartford Kent, England, United Kingdom

  • Derbyshire Royal Infirmary

    Derby, England, United Kingdom

  • Dewsbury and District Hospital

    Dewsbury, England, United Kingdom

  • Doncaster Royal Infirmary

    Doncaster, England, United Kingdom

  • Russells Hall Hospital

    Dudley, England, United Kingdom

  • University Hospital of North Durham

    Durham, England, United Kingdom

  • Eastbourne District General Hospital

    Eastbourne, England, United Kingdom

  • Royal Devon and Exeter Hospital

    Exeter, England, United Kingdom

  • Queen Elizabeth Hospital

    Gateshead, England, United Kingdom

  • Gloucestershire Royal Hospital

    Gloucester, England, United Kingdom

  • Diana Princess of Wales Hospital

    Grimsby, England, United Kingdom

Showing 40 of 152 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.